ADIPOQ and type 2 diabetes mellitus: In a recent meta-analysis, our team found that DPP-4i increased serum levels of adiponectin in T2DM, an adipose-specific protein which is negatively correlated with proatherogenic LDL-C and other cardiovascular risk factors for diabetes or IR [42].